Exact Mass: 356.104

Exact Mass Matches: 356.104

Found 13 metabolites which its exact mass value is equals to given mass value 356.104, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

(SC2RC7RS)-gamma-glutamyl-S-benzylcysteine sulfoxide|(SC2RC7SS)-gamma-glutamyl-S-benzylcysteine sulfoxide|gamma-L-glutamyl-petiveriin A|gamma-L-glutamyl-petiveriin B|??-L-Glutamyl-petiveriin A|??-L-Glutamyl-petiveriin B

(SC2RC7RS)-gamma-glutamyl-S-benzylcysteine sulfoxide|(SC2RC7SS)-gamma-glutamyl-S-benzylcysteine sulfoxide|gamma-L-glutamyl-petiveriin A|gamma-L-glutamyl-petiveriin B|??-L-Glutamyl-petiveriin A|??-L-Glutamyl-petiveriin B

C15H20N2O6S (356.1042)


   

Met-Val-OH

(S)-4-methyl-2-(3-(2-(methylthio)ethoxy)-4-nitrobenzamido)pentanoic acid

C15H20N2O6S (356.1042)


   

Val-Met-OH

(S)-2-(3-isopropoxy-4-nitrobenzamido)-5-(methylthio)pentanoic acid

C15H20N2O6S (356.1042)


   

Pyrantel tartrate

Pyrantel tartrate

C15H20N2O6S (356.1042)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent Pyrantel tartrate is an orally active anthelmintic and an agonist of the nicotinic acetylcholine receptor (nAChR). Pyrantel tartrate can cause spasmodic muscle paralysis in parasites. Pyrantel tartrate can be used in the study of parasitic infections such as ascariasis, hookworm infections, intestinal worms (pinworm infections), trichinosis and trichinosis[1][2].

   

(5R)-3-{3-Fluoro-4-[6-(2H-tetrazol-5-yl)-3-pyridinyl]phenyl}-5-(hydroxymethyl)-1,3-oxazolidin-2-one

(5R)-3-{3-Fluoro-4-[6-(2H-tetrazol-5-yl)-3-pyridinyl]phenyl}-5-(hydroxymethyl)-1,3-oxazolidin-2-one

C16H13FN6O3 (356.1033)


   

Benzoic acid, 4-methyl-, 4-oxo-2-phenyl-4H-1-benzopyran-3-yl ester

Benzoic acid, 4-methyl-, 4-oxo-2-phenyl-4H-1-benzopyran-3-yl ester

C23H16O4 (356.1049)


   

1-(3-CHLOROPHENYL)-3-(1,5-DIMETHYL-3-OXO-2-PHENYL-2,3-DIHYDRO-1H-PYRAZOL-4-YL)UREA

1-(3-CHLOROPHENYL)-3-(1,5-DIMETHYL-3-OXO-2-PHENYL-2,3-DIHYDRO-1H-PYRAZOL-4-YL)UREA

C18H17ClN4O2 (356.104)


   

3-[(4-Chloroanilino)methylidene]-2-(2-hydroxyethylimino)-9-methyl-4-pyrido[1,2-a]pyrimidinone

3-[(4-Chloroanilino)methylidene]-2-(2-hydroxyethylimino)-9-methyl-4-pyrido[1,2-a]pyrimidinone

C18H17ClN4O2 (356.104)


   

Protoviolaceinate

Protoviolaceinate

C21H14N3O3- (356.1035)


   

Deoxyviolaceinate

Deoxyviolaceinate

C21H14N3O3- (356.1035)


A monocarboxylic acid anion that is the conjugate base of deoxyviolaceinic acid, resulting from the removal of the proton from the carboxy group. Major structure at pH 7.3.

   

N-[3-(3-chlorophenyl)-5-isoxazolyl]-2-(4,5,6,7-tetrahydroindazol-2-yl)acetamide

N-[3-(3-chlorophenyl)-5-isoxazolyl]-2-(4,5,6,7-tetrahydroindazol-2-yl)acetamide

C18H17ClN4O2 (356.104)


   

2-amino-4-[(1-carboxy-2-phenylmethanesulfinylethyl)-c-hydroxycarbonimidoyl]butanoic acid

2-amino-4-[(1-carboxy-2-phenylmethanesulfinylethyl)-c-hydroxycarbonimidoyl]butanoic acid

C15H20N2O6S (356.1042)


   

(2s)-2-amino-4-{[(1r)-1-carboxy-2-[(r)-phenylmethanesulfinyl]ethyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s)-2-amino-4-{[(1r)-1-carboxy-2-[(r)-phenylmethanesulfinyl]ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C15H20N2O6S (356.1042)